Alfonso Luis de Oyarzabal Sanz

Investigador post-doc

Research group

Illescas S, Diaz-Osorio Y, Serradell A, Toro-Soria L, Musokhranova U, Julià-Palacios NA, Ribeiro J, Altafaj X, Olivella M, O'Callaghan-Gordo M, Darling A, Armstrong-Moron J, Artuch-Iriberri R, Garcia-Cazorla A and De Oyarzabal-Sanz AL Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmission JOURNAL OF INHERITED METABOLIC DISEASE 2023. : .
Musokhranova U, Grau-Páez C, Vergara C, Rodríguez-Pascau L, Xiol-Viñas C, Castells AA, Alcántara S, Rodríguez-Pombo P, Pizcueta P, Martinell M, Garcia-Cazorla A and De Oyarzabal-Sanz AL Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome JOURNAL OF TRANSLATIONAL MEDICINE 2023. 21(1): 756-756.
Tangeraas T, Ribeiro J, Backe PH, De Oyarzabal-Sanz AL, Neugebauer J, Weinhold N, Boemer F, Debray FG, Ozturk-Hism B, Evren G, Tuba EF, Ummuhan O, Footitt E, Davison J, Martinez C, Bueno C, Machado I, Rodríguez-Pombo P, Al-Sannaa N, de los Santos MM, Muchart-Lopez J, Ozturkmen-Akay H, Karaca M, Tekin M, Pajares S, Ormazabal-Herrero A, Stoway SD, Artuch-Iriberri R, Dixon M, Mørkrid L and Garcia-Cazorla A BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening BRAIN 2023. 146(7): 3003-3013.

More Publications

Project name:: Enfermedad es Bpan
Leader: Alejandra Darling , Alfonso Luis De Oyarzabal Sanz
Funding entities:: ZZZZ_O.H.S.J.D.-Curia Provincial, Provincia San Juan de Dios de España
Code: PFNR0186
Starting - finishing date:: 2023

Project name:: Entrega de MeCP2 en el cerebro mediante el uso de nanocápsulas para el tratamiento del síndrome de Rett
Leader: Alfonso Luis De Oyarzabal Sanz
Funding entities:: Generalitat de Catalunya
Code: SLT033/23/000097
Starting - finishing date:: 2023 - 2024

Project name:: Development of leriglitazone for Rett Syndrome and related disorders
Leader: MªAngels García Cazorla, Alfonso Luis De Oyarzabal Sanz
Funding entities:: Ministerio De Ciencia E Innovacion
Code: CPP2021-008554
Starting - finishing date:: 2022 - 2025

More projects

Advances in Research on Rett Syndrome
Friday, 24 November 2023
A study conducted by the Paediatric Neurometabolic Disorders: Neural Communication Mechanisms and Personalised Therapies Group at IRSJD · SJD Barcelona Children's Hospital confirms mitochondrial dysfunction in two distinct models of Rett syndrome, highlighting the significance of distinguishing between brain regions and stages of the disease. The findings of this study open up new avenues for treatment development.

See All news

More activities